Citicoline (CDP-choline) is sold in the United States as a dietary supplement, not as an FDA-approved drug. Because of that, no regulator has checked whether it treats any disease. If you are thinking about taking it, the smartest step is a conversation with a citicoline doctor conversation, that is, a real talk with your own physician before you start. This page gives you a list of questions to bring. It is a question list, not medical advice.
The evidence behind citicoline is mixed, and some of it is negative. In acute stroke, the large ICTUS trial (Dávalos, Lancet 2012, about 2,300 people) found no improvement in 90-day recovery versus placebo. In traumatic brain injury, the COBRIT trial (Zafonte, JAMA 2012) found no improvement in functional or cognitive outcomes versus placebo. Smaller studies suggest possible benefits for memory in chronic cerebrovascular decline and for attention in healthy adults and adolescents, but those findings are weaker. A doctor can help you weigh all of this against your own health situation.
One safety note before the questions. If you or someone near you shows signs of a stroke, face drooping, arm weakness, speech trouble, sudden confusion, call emergency services immediately. Do not take a supplement, and do not fill out a web form. Also, the contact form on this site is not a medical visit and does not create a doctor-patient relationship. This page, /supplements/questions-for-your-doctor/, is a preparation tool only.
Evidence at a glance
| Question | Best evidence | Tier | Bottom line |
|---|---|---|---|
| Does it help after an acute stroke? | ICTUS (Dávalos, Lancet 2012, ~2,300 people) | T1 | No improvement in 90-day recovery versus placebo |
| Did earlier stroke research look better? | Earlier stroke meta-analyses | T2 | Suggested benefit, but not confirmed by ICTUS |
| Does it help after traumatic brain injury? | COBRIT (Zafonte, JAMA 2012) | T1 | No improvement in functional or cognitive outcomes |
| Does it help memory in chronic cerebrovascular decline? | Cochrane review (Fioravanti and Yanagi) | T2 | Modest short-term benefit; trials short and low quality |
| Does it help mild vascular cognitive impairment? | IDEALE (Cotroneo) | T3a | Observational; stable scores versus decline in untreated group |
| Does it help attention in healthy people? | McGlade 2012 (women); McGlade (adolescent males) | T1 small | Better attention-test scores; industry funded |
| Does it treat ADHD? | No adequate trials | , | There is no good evidence citicoline treats ADHD |
| Is it safe? | Trial safety data, 250, 2,000 mg/day | , | Generally well tolerated; mild GI upset, headache, insomnia |
Why the negative results belong in the conversation
Many people only bring a doctor the hopeful findings. That leads to a lopsided talk. The two largest, best-run trials of citicoline, ICTUS in stroke and COBRIT in brain injury, both found no benefit over placebo. Earlier stroke meta-analyses had suggested a benefit, but the bigger trial did not confirm it. That pattern matters: small positive studies often shrink or disappear when tested properly. Bring both sides of the evidence to your appointment, and ask your doctor how they weigh a large negative trial against smaller positive ones.
What the weaker findings actually mean
The supportive evidence is real but limited. The Cochrane review on chronic cerebrovascular cognitive decline found modest short-term benefit on memory and behaviour, but the trials were short and low quality. The IDEALE study in mild vascular cognitive impairment was observational, people were not randomly assigned, so it cannot prove the supplement caused the stable scores. The McGlade attention studies were small and funded by Cognizin, a citicoline brand; industry funding does not make results false, but it is a fair question to raise. Small glaucoma trials showed changes in electrical signals from the eye, but whether citicoline slows vision loss is not established. And for ADHD, there are simply no adequate trials.
Safety questions worth asking out loud
Citicoline was generally well tolerated in trials at 250 to 2,000 mg per day. The most common complaints were mild stomach upset, headache, and insomnia. But "well tolerated in trials" is not the same as "right for you." Pregnancy and breastfeeding data are lacking, so that is an essential question if it applies to you. Citicoline may also enhance the effects of levodopa, so anyone with Parkinson's disease should involve their neurologist before taking it. Bring a full list of your medicines and supplements to the visit. For more background, see our pages on [/evidence/](the citicoline evidence base), [/safety/side-effects/](reported side effects), and [/safety/dosage/](what doses were used in trials).
Expert insight
I am Dr. Alexander Tabibi, and my honest summary is this: the strongest trials we have, ICTUS in stroke and COBRIT in traumatic brain injury, found no benefit of citicoline over placebo. The positive findings come from smaller, shorter, or observational studies, and two of the attention trials were funded by a company that sells the ingredient. Citicoline is a dietary supplement, not an FDA-approved treatment, and there is no good evidence it treats ADHD. That does not mean no one should consider it, it means the decision should be made with full information. A short visit with your own physician, armed with specific questions, is worth far more than any article, including this one. Write your questions down before you go.
Questions readers ask
Is citicoline the same as CDP-choline?
Yes. They are the same compound. Cognizin is a brand of it. Ask your doctor to look at the exact ingredient and dose on your label.
Can I take citicoline instead of my prescribed medicine?
No. It is a supplement, not an approved drug, and it failed to beat placebo in the large stroke and brain injury trials. Never stop or replace a prescription without your doctor.
Should I take citicoline after a stroke?
The large ICTUS trial found no improvement in 90-day recovery versus placebo. Acute stroke is an emergency, call emergency services first, and discuss any supplement with your care team afterward.
Is citicoline safe with my other medicines?
It was generally well tolerated in trials, but it may enhance levodopa's effects. If you have Parkinson's disease, involve your neurologist. Bring your full medicine list to the visit.
Can citicoline help my child's ADHD?
There are no adequate trials for ADHD, and no good evidence it treats the condition. Ask your doctor about proven ADHD treatments instead.
Is citicoline safe during pregnancy or breastfeeding?
The data are lacking. This is a question only your own clinician can answer for your situation.
The contact form said I'd get a reply, is that a consultation?
No. The contact form is not a visit and does not create a doctor-patient relationship. Use it for site questions, then take your health questions to your own doctor.
Sources
- ICTUS trial, Dávalos et al., Lancet 2012 (acute stroke)
- COBRIT trial, Zafonte et al., JAMA 2012 (traumatic brain injury)
- Cochrane review, Fioravanti and Yanagi (chronic cerebrovascular cognitive decline)
- IDEALE study, Cotroneo et al. (mild vascular cognitive impairment)
- McGlade et al. 2012 (adult attention) and McGlade et al. (adolescent attention), both Cognizin-funded
- Small glaucoma trials, Parisi and Rossetti groups
PMIDs are not listed here until each one is confirmed on PubMed.
